Clover Health (CLOV) PT Raised to $9 at Credit Suisse
Tweet
Share
E-mailGet Alerts CLOV Hot Sheet
Price: $4.23 --0%
Rating Summary:
2 Buy, 4 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 5 | New: 3
Rating Summary:
2 Buy, 4 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 5 | New: 3
Join SI Premium – FREE
Credit Suisse analyst Jonathan Yong raised the price target on Clover Health (NASDAQ: CLOV) to $9.00 (from $8.00) while maintaining a Neutral rating.
You May Also Be Interested In
- Freedom Broker Downgrades Workday (WDAY) to Hold
- Goldman Sachs Upgrades Bapcor Ltd. (BAP:AU) to Neutral
- Zhejiang Sanhua Intelligent Controls (002050:CH) PT Lowered to RMB24.20 at Macquarie
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
